Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-α in chemotherapy of multidrug-resistant hepatocellular carcinoma
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2009.02113.x/fullpdf
Reference48 articles.
1. 1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-37.
2. 2. Boucher E , Forner A , Reig M , Bruix J. New drugs for the treatment of hepatocellular carcinoma. Liver Int 2009; 29 (Suppl. 1): 148-58.
3. 3. Doyle LA , Yang W , Abruzzo LV , et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998; 95: 15665-70.
4. 4. Kowalski P , Stein U , Scheffer GL , Lage H. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther 2002; 9: 579-86.
5. 5. Uchino J , Une Y , Kawata A , Wakisaka Y , Hosokawa M. Postoperative chemoimmunotherapy for the treatment of liver cancer. Semin Surg Oncol 1993; 9: 332-6.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy;Nano Research;2024-04-04
2. Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma;Journal of Nanobiotechnology;2023-02-27
3. Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform—Physicochemical Properties and In Vitro Studies on Mastocytoma Cells;International Journal of Molecular Sciences;2022-02-09
4. Immobilization of Paclitaxel on Hydroxyapatite for Breast Cancer Investigations;Langmuir;2020-07-09
5. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis;Experimental Biology and Medicine;2020-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3